TRVI
Trevi Therapeutics Inc.
$8.55
+$0.40(+4.91%)
63
Overall
--
Value
63
Tech
--
Quality
Market Cap
$992.48M
Volume
1.46M
52W Range
$2.36 - $9.92
Target Price
$20.36
EPS Estimates Overview
| Current Quarter | $-0.1 | Next Quarter | $-0.11 |
| Current Year | $-0.39 | Next Year | $-0.54 |
| QoQ Growth | -10.0% | YoY Growth | -38.5% |
| 3Y EPS CAGR | N/A | Target Price | $20.36 |
| Consensus | Buy | Upside | +138.1% |
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | TRVI | $8.55 | +4.9% | 1.46M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |